| Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose A De Titta, M Ballester, Z Julier, C Nembrini, L Jeanbart, AJ Van Der Vlies, ... Proceedings of the National Academy of Sciences 110 (49), 19902-19907, 2013 | 292 | 2013 |
| Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma M Fankhauser, MAS Broggi, L Potin, N Bordry, L Jeanbart, AW Lund, ... Science translational medicine 9 (407), eaal4712, 2017 | 214 | 2017 |
| Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity DS Wilson, S Hirosue, MM Raczy, L Bonilla-Ramirez, L Jeanbart, R Wang, ... Nature materials 18 (2), 175-185, 2019 | 194 | 2019 |
| Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes L Jeanbart, M Ballester, A De Titta, P Corthésy, P Romero, JA Hubbell, ... Cancer immunology research 2 (5), 436-447, 2014 | 191 | 2014 |
| Engineering opportunities in cancer immunotherapy L Jeanbart, MA Swartz Proceedings of the National Academy of Sciences 112 (47), 14467-14472, 2015 | 144 | 2015 |
| 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice L Jeanbart, IC Kourtis, AJ Van Der Vlies, MA Swartz, JA Hubbell Cancer Immunology, Immunotherapy 64, 1033-1046, 2015 | 69 | 2015 |
| Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice M Ballester, L Jeanbart, A De Titta, C Nembrini, BJ Marsland, JA Hubbell, ... Scientific reports 5 (1), 14274, 2015 | 49 | 2015 |
| The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine Z Julier, MM Martino, A De Titta, L Jeanbart, JA Hubbell Scientific reports 5 (1), 8569, 2015 | 49 | 2015 |
| Development of a nanoparticulate formulation of retinoic acid that suppresses Th17 cells and upregulates regulatory T cells NA Capurso, M Look, L Jeanbart, H Nowyhed, J Craft, C Abraham, ... Self/nonself 1 (4), 335-340, 2010 | 38 | 2010 |
| Neuromodulating compositions and related therapeutic methods for the treatment of cancer by modulating an anti-cancer immune response E Weinstein, J Mata-Fink, A Kahvejian, NB Afeyan, LK Jeanbart, ... US Patent App. 16/320,342, 2019 | 7 | 2019 |
| A localizable, biological-based system for the delivery of bioactive IGF-1 utilizing microencapsulated genetically modified human fibroblasts RS Patel, TM Temu, L Jeanbart, JR Morgan, MJ Lysaght ASAIO Journal 55 (3), 259-265, 2009 | 5 | 2009 |
| Neuromodulating compositions and related therapeutic methods for the treatment of inflammatory and autoimmune diseases E Weinstein, J Mata-Fink, A Kahvejian, NB Afeyan, LK Jeanbart, ... US Patent App. 16/320,321, 2021 | 1 | 2021 |
| Neuromodulating compositions and related therapeutic methods for the treatment of cancer E Weinstein, J Mata-Fink, A Kahvejian, NB Afeyan, LK Jeanbart, ... US Patent App. 17/023,778, 2021 | 1 | 2021 |
| Recombinant cd3 binding proteins and their use S Grimm, N Reschke, C Reichen, B Schlereth, V Levitsky, L Jeanbart US Patent App. 18/267,608, 2024 | | 2024 |
| Recombinant cd3 binding proteins and their use S Grimm, N Reschke, C Reichen, B Schlereth, V Levitsky, L Jeanbart WO Patent App. PCT/EP2021/086,331, 2022 | | 2022 |
| Novel DARPin multi-specific T-cell engager with an improved therapeutic window to overcome dose limiting toxicities in AML therapies N Reschke, T Looser, J Krieg, M Bianchi, P Schildknecht, N Bassler, ... Cancer Research 81 (13_Supplement), 525-525, 2021 | | 2021 |
| Neuromodulating compositions and related therapeutic methods for the treatment of cancer by modulating an anti-cancer immune response E Weinstein, J Mata-Fink, A Kahvejian, NB Afeyan, LK Jeanbart, ... US Patent App. 17/063,258, 2021 | | 2021 |
| Advances in T Cell Immunotherapy TJ Harris, S Farkona, K Urbanska, L Jeanbart, N Maeda, P Straten Advances in T Cell Immunotherapy, 330, 2016 | | 2016 |
| Materials and protein engineering approaches for modulating immunity J Hubbell, M Swartz, M Ballester, A De Titta, L Jeanbart, S Kontos, ... Abstracts Of Papers Of The American Chemical Society 247, 2014 | | 2014 |
| Targeting and Modulating Tumor-Associated Sites with Novel Nanoparticle-Based Immunotherapies L Jeanbart EPFL, 2013 | | 2013 |
